MRTX849

cas: 2326521-71-3 — see every product listed under this CAS number, including other names

MRTX849 (CAS 2326521-71-3) is a chemical reagent available from Chemat. Available pack sizes: 10mg, 100mg, 1g, 25mg, 5mg, 10mM (in 1ml dmso), 50mg, 500mg. Offered by: GLPBio, Biosynth.

brandGLPBio
catalog numberGC38400-10
cas2326521-71-3
size10mg
Need more information?

Ask us about this product — we're happy to help.

Available pack sizes

brand size price
GLPBio 10mg 788.94 Pln
GLPBio 100mg 2642.42 Pln
GLPBio 1g 11685.14 Pln
GLPBio 25mg 1233.59 Pln
GLPBio 5mg 690.65 Pln
GLPBio 10mM (in 1ml dmso) 835.75 Pln
GLPBio 50mg 1888.86 Pln
GLPBio 500mg 7458.65 Pln
Biosynth 5mg price on request
Biosynth 10mg price on request
Biosynth 25mg price on request

properties

purityNo data
delivery timeTo be confirmed by Chemat
Structural formula: {0} (CAS {1})

Adagrasib (MRTX849) is an oral, small-molecule KRAS inhibitor developed by Mirati Therapeutics. KRAS mutations are highly common in cancer and account for approximately 85% of all RAS family mutations.

Source: ChEBI

Identity
Molecular formulaC32H35ClFN7O2
Molecular weight604.1 g/mol
IUPAC name2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile
InChIKeyPEMUGDMSUDYLHU-ZEQRLZLVSA-N
SMILESCN1CCC[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F

Computed by PubChem (NCBI)

Also listed as